|
|
|
21 Feb 2007 |
Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
|
|
21 Feb 2007 |
Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
|
|
17 Feb 2007 |
OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
|
|
16 Feb 2007 |
Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
|
|
16 Feb 2007 |
FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
|
|
15 Feb 2007 |
Halozyme and Baxter Expand Global HYLENEX Collaboration
|
|
15 Feb 2007 |
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
|
|
14 Feb 2007 |
Sangart, Inc. Initiates Phase III Clinical Trials
|
|
13 Feb 2007 |
Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
|
|
13 Feb 2007 |
QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
|
|
09 Feb 2007 |
Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
|
|
09 Feb 2007 |
EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
|
|
09 Feb 2007 |
LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
|
|
09 Feb 2007 |
Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
|
|
09 Feb 2007 |
Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod)
|
|
07 Feb 2007 |
Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
|
|
07 Feb 2007 |
Gloucester Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial in Patients with Multiple Myeloma
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
|
|
03 Feb 2007 |
Adnexus Therapeutics Announces Presentation Of Interim Phase I Results For CT-322, First Adnectin Therapeutic In Humans
|
|
02 Feb 2007 |
Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
|
|
02 Feb 2007 |
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
|
|
02 Feb 2007 |
Grifols announces FDA approval of Alphanate(R) to treat von Willebrand disease
|
|
02 Feb 2007 |
Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
|
|
31 Jan 2007 |
Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
|
|
31 Jan 2007 |
OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
|
|
31 Jan 2007 |
ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
|
|
31 Jan 2007 |
Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE(R) for Treatment of Malignant Mesothelioma
|
|
30 Jan 2007 |
ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
|
|
27 Jan 2007 |
Largest-ever stroke registry confirms safety of Actilyse(R) thrombolysis treatment for acute ischaemic stroke
|
|
26 Jan 2007 |
Bayer discontinues Trasylol(R) clinical trial program in non-CABG indications
|
|
26 Jan 2007 |
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
|
|
26 Jan 2007 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
|
|
26 Jan 2007 |
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
|
|
25 Jan 2007 |
Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
|
|
25 Jan 2007 |
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta(TM) (Formerly OctreoTher(TM))
|
|
23 Jan 2007 |
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
|
|
23 Jan 2007 |
Discovery Labs and FDA Reach Clarity On Path Towards Surfaxin RDS Approval
|
|
23 Jan 2007 |
MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by Partner, Cutanea Life Sciences
|
|
23 Jan 2007 |
Artielle ImmunoTherapeutics, Inc., and QSV Biologics, Ltd. Sign Contract for cGMP Manufacture of RTL 1000 for Multiple Sclerosis
|
|
19 Jan 2007 |
Protox Reports Promising Interim Results From Prostate Cancer Study
|
|
19 Jan 2007 |
CSC'S DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
|
|
18 Jan 2007 |
MGI PHARMA Announces Publication of Phase 3 Data for Saforis(TM) (glutamine) Powder in UpTec(TM) for Oral Suspension in Cancer
|
|
18 Jan 2007 |
Lev Pharmaceuticals, Inc. Announces Final Patient Treated In Pivotal Phase III HAE Trial
|
|
17 Jan 2007 |
Oxford Biomedica Announces Publication Of Avian Transgenic Results In Leading U.S. Scientific Journal
|
|
17 Jan 2007 |
Largest-ever Fabry study shows earlier treatment with (Pr)Fabrazyme(R) 1 mg/kg means less damage from rare Fabry disease
|
|
17 Jan 2007 |
Pharming Receives European Orphan Drug Designation
|
|
17 Jan 2007 |
Neose Receives Approval to Commence Phase II Clinical Trial For NE-180
|
|
16 Jan 2007 |
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients with Type 1 Gaucher Disease
|
|
16 Jan 2007 |
FDA accepts for filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
|
| |
|
Results 901 - 950 of 1495 |
